Variant report

Variant	nsv960420
Chromosome Location	chr17:15495503-15527069
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:163)
CpG islands
(count:367)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:163 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:15520261-15520519	HepG2	liver:	n/a	n/a
2	BATF	chr17:15499439-15499718	GM12878	blood:	n/a	chr17:15499580-15499591
3	BATF	chr17:15516677-15517084	GM12878	blood:	n/a	n/a
4	BATF	chr17:15512843-15513108	GM12878	blood:	n/a	n/a
5	BATF	chr17:15516715-15517005	GM12878	blood:	n/a	n/a
6	CEBPB	chr17:15512877-15513031	IMR90	lung:	n/a	n/a
7	CTCF	chr17:15512617-15512899	A549	lung:	n/a	n/a
8	CTCF	chr17:15512715-15512913	ProgFib	skin:	n/a	n/a
9	CTCF	chr17:15525283-15525299	MCF-7	breast:	n/a	n/a
10	CTCF	chr17:15512687-15512899	HepG2	liver:	n/a	n/a
11	CTCF	chr17:15512728-15512892	Gliobla	brain:	n/a	n/a
12	CTCF	chr17:15512718-15512908	A549	lung:	n/a	n/a
13	CTCF	chr17:15512707-15512915	NHEK	skin:	n/a	n/a
14	CTCF	chr17:15522700-15522850	AG10803	skin:	n/a	n/a
15	CTCF	chr17:15508816-15508846	LNCaP	prostate:	n/a	n/a
16	CTCF	chr17:15512559-15513044	A549	lung:	n/a	n/a
17	CTCF	chr17:15512693-15512933	A549	lung:	n/a	n/a
18	CTCF	chr17:15512732-15512903	HUVEC	blood vessel:	n/a	n/a
19	CTCF	chr17:15512698-15512883	LNCaP	prostate:	n/a	n/a
20	CTCF	chr17:15512783-15512887	GM10266	blood:	n/a	n/a
21	CTCF	chr17:15522780-15522930	HAc	cerebellar:	n/a	chr17:15522887-15522895
22	CTCF	chr17:15512737-15512901	LNCaP	prostate:	n/a	n/a
23	CTCF	chr17:15512756-15512898	Pancreas_OC	pancreas:	n/a	n/a
24	CTCF	chr17:15512763-15512893	H1-hESC	embryonic stem cell:	n/a	n/a
25	CTCF	chr17:15512745-15512904	Kidney_OC	kidney:	n/a	n/a
26	CTCF	chr17:15514800-15514950	HCPEpiC	choroid plexus:	n/a	n/a
27	CTCF	chr17:15521407-15521414	Kidney_OC	kidney:	n/a	n/a
28	CTCF	chr17:15522680-15522830	HBMEC	blood vessel:	n/a	n/a
29	CTCF	chr17:15512745-15512854	GM19240	blood:	n/a	n/a
30	CTCF	chr17:15499797-15499848	GM20000	blood:	n/a	n/a
31	CTCF	chr17:15512702-15512913	MCF-7	breast:	n/a	n/a
32	CTCF	chr17:15512754-15512885	Fibrobl	skin:	n/a	n/a
33	CTCF	chr17:15512711-15512906	K562	blood:	n/a	n/a
34	CTCF	chr17:15512640-15512790	HCPEpiC	choroid plexus:	n/a	n/a
35	CTCF	chr17:15512719-15512724	MCF-7	breast:	n/a	n/a
36	CTCF	chr17:15512693-15512926	MCF-7	breast:	n/a	n/a
37	CTCF	chr17:15512688-15512917	Hela-S3	cervix:	n/a	n/a
38	CTCF	chr17:15512674-15512924	MCF-7	breast:	n/a	n/a
39	CTCF	chr17:15522766-15522802	HUVEC	blood vessel:	n/a	n/a
40	CTCF	chr17:15522308-15522382	GM13976	blood:	n/a	n/a
41	CTCF	chr17:15508519-15508566	GM13976	blood:	n/a	n/a
42	CTCF	chr17:15512727-15512911	Lung_OC	lung:	n/a	n/a
43	CTCF	chr17:15512662-15512955	MCF-7	breast:	n/a	n/a
44	CTCF	chr17:15512752-15512847	GM19238	blood:	n/a	n/a
45	CTCF	chr17:15512744-15512824	GM10248	blood:	n/a	n/a
46	CTCF	chr17:15512824-15512837	GM12892	blood:	n/a	n/a
47	CTCF	chr17:15521351-15521401	Kidney_OC	kidney:	n/a	n/a
48	CTCF	chr17:15512726-15512896	Spleen_OC	spleen:	n/a	n/a
49	CTCF	chr17:15508796-15508804	LNCaP	prostate:	n/a	n/a
50	CTCF	chr17:15512623-15513020	A549	lung:	n/a	n/a

(count:367 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:15522897-15522947	SAEC	small airway:	n/a
2	chr17:15522897-15522947	SAEC	small airway:	n/a
3	chr17:15524026-15524076	Jurkat	blood:	n/a
4	chr17:15519323-15519373	GM12892	blood:	n/a
5	chr17:15523999-15524049	Hepatocyte	liver:	n/a
6	chr17:15519323-15519373	GM19239	blood:	n/a
7	chr17:15522897-15522947	Hepatocyte	liver:	n/a
8	chr17:15524026-15524076	GM19239	blood:	n/a
9	chr17:15522876-15522926	HIPEpiC	eye:	n/a
10	chr17:15522876-15522926	AG04450	lung:	fetal
11	chr17:15523510-15523560	HRE	kidney:	n/a
12	chr17:15523510-15523560	HMEC	breast:	n/a
13	chr17:15519323-15519373	BE2_C	brain:	n/a
14	chr17:15522897-15522947	HL-60	blood:	n/a
15	chr17:15522876-15522926	HUVEC	blood vessel:	n/a
16	chr17:15523510-15523560	MCF-7	breast:	n/a
17	chr17:15523999-15524049	GM19239	blood:	n/a
18	chr17:15524026-15524076	HIPEpiC	eye:	n/a
19	chr17:15522897-15522947	HEK293	kidney:	embryo
20	chr17:15524026-15524076	HCF	heart:	n/a
21	chr17:15522876-15522926	HMEC	breast:	n/a
22	chr17:15523510-15523560	PFSK-1	brain:	n/a
23	chr17:15523510-15523560	Caco-2	colon:	n/a
24	chr17:15522897-15522947	RPTEC	kidney:	n/a
25	chr17:15522876-15522926	A549	lung:	n/a
26	chr17:15519323-15519373	AG09319	gingival:	n/a
27	chr17:15523999-15524049	PrEC	prostate:	n/a
28	chr17:15522876-15522926	T-47D	breast:	n/a
29	chr17:15523999-15524049	CMK	blood:	n/a
30	chr17:15522876-15522926	BE2_C	brain:	n/a
31	chr17:15524026-15524076	K562	blood:	n/a
32	chr17:15522897-15522947	AG09309	skin:	n/a
33	chr17:15523510-15523560	BE2_C	brain:	n/a
34	chr17:15523510-15523560	T-47D	breast:	n/a
35	chr17:15524026-15524076	SK-N-SH_RA	brain:	n/a
36	chr17:15522876-15522926	HCPEpiC	choroid plexus:	n/a
37	chr17:15523999-15524049	HCF	heart:	n/a
38	chr17:15523510-15523560	NB4	blood:	n/a
39	chr17:15523510-15523560	SK-N-SH	brain:	n/a
40	chr17:15523999-15524049	BE2_C	brain:	n/a
41	chr17:15523999-15524049	GM12892	blood:	n/a
42	chr17:15522897-15522947	HCM	heart:	n/a
43	chr17:15519323-15519373	GM06990	blood:	n/a
44	chr17:15519323-15519373	HEK293	kidney:	embryo
45	chr17:15523999-15524049	PFSK-1	brain:	n/a
46	chr17:15522897-15522947	K562	blood:	n/a
47	chr17:15523510-15523560	MCF10A-Er-Src	breast:	n/a
48	chr17:15524026-15524076	T-47D	breast:	n/a
49	chr17:15522876-15522926	NHBE	bronchial:	n/a
50	chr17:15522897-15522947	AoSMC	blood vessel:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr17:15523258..15525721-chr17:15553845..15555566,2	MCF-7	breast:

No data

Variant related genes	Relation type
CDRT1	TF binding region
CDRT1	CpG island
ENSG00000251537	chromatin interactions
ENSG00000266261	chromatin interactions

Extended variants
information (count: 1427 )
Associated
traits (count: 129 )

Variant overlapped rSNPs/rCNVs (count:1427 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs562362898	chr17:15495510-15495511	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
2	rs149384598	chr17:15495538-15495539	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs62070374	chr17:15495607-15495608	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs79748892	chr17:15495612-15495613	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs79488810	chr17:15495614-15495615	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs73978083	chr17:15495615-15495616	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs544988133	chr17:15495632-15495633	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs66564437	chr17:15495633-15495634	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs551232940	chr17:15495682-15495683	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs184693084	chr17:15495708-15495709	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
11	rs188713133	chr17:15495711-15495712	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs536545141	chr17:15495767-15495768	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs547987764	chr17:15495819-15495820	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs181403408	chr17:15495836-15495837	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs536960654	chr17:15495840-15495841	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs199606047	chr17:15495855-15495856	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs373073690	chr17:15495857-15495858	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs566531829	chr17:15495943-15495944	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs558825495	chr17:15495945-15495946	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs374410301	chr17:15495956-15495957	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs142732771	chr17:15496101-15496102	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs553574802	chr17:15496141-15496142	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs183766999	chr17:15496146-15496147	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs573469967	chr17:15496147-15496148	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs542558736	chr17:15496148-15496149	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs188386928	chr17:15496153-15496154	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs575992796	chr17:15496173-15496174	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs146153411	chr17:15496180-15496181	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs182317078	chr17:15496184-15496185	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs140162266	chr17:15496190-15496191	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs547479694	chr17:15496200-15496201	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs374411308	chr17:15496235-15496236	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs377671253	chr17:15496241-15496242	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs187232478	chr17:15496252-15496253	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs530272135	chr17:15496270-15496271	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs550255241	chr17:15496274-15496275	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs143894060	chr17:15496275-15496276	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs532436815	chr17:15496291-15496292	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs552524331	chr17:15496317-15496318	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs565711099	chr17:15496341-15496342	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs2602000	chr17:15496343-15496344	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs201725077	chr17:15496372-15496373	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs370972554	chr17:15496416-15496417	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs554543656	chr17:15496490-15496491	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs567167277	chr17:15496524-15496525	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs536435342	chr17:15496542-15496543	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs556217274	chr17:15496551-15496552	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs576263117	chr17:15496575-15496576	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs544946076	chr17:15496584-15496585	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs558599783	chr17:15496587-15496588	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:129)

Disease	PMID	Source
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	17603634	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	19435819	CNVD
Non-small cell lung cancer	19010865	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16774939	CNVD
Hepatocellular carcinoma	18803288	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Multiple myeloma	16616336	CNVD
Multiple myeloma	17550852	CNVD
Breast cancer	21509527	CNVD
Pancreatic cancer	21811587	CNVD
Autism	17322880	CNVD
Hereditary neuropathy with liability to pressure palsy	19521722	CNVD
Schizophrenia	19571808	CNVD
Schizophrenia	19955444	CNVD
Charcot-marie-tooth disease	18787571	CNVD
Breast cancer	20409316	CNVD
Autism	18414403	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Myelofibrosis	22110671	CNVD
Peripheral neuropathy	21193943	CNVD
Schizophrenia	20587603	CNVD
Schizophrenia	22958593	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Ovarian cancer	20844748	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
ovarian endometriomas	16273235	CNVD
Breast cancer	21858162	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17142309	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22102821	CNVD
Gastric cancer	18160780	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	19212409	CNVD

Chromatin state (count:118 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:15491600-15501800	Weak transcription	Esophagus	oesophagus
2	chr17:15492200-15497000	Enhancers	Primary T cells fromperipheralblood	blood
3	chr17:15492200-15497000	Enhancers	Primary hematopoietic stem cells short term culture	blood
4	chr17:15492400-15495600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
5	chr17:15492800-15496400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
6	chr17:15493000-15501000	Weak transcription	A549	lung
7	chr17:15493600-15495600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr17:15493600-15497200	Enhancers	Primary T regulatory cells fromperipheralblood	blood
9	chr17:15493800-15495600	Enhancers	Primary hematopoietic stem cells	blood
10	chr17:15494000-15495600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
11	chr17:15494000-15495600	Enhancers	Primary T helper naive cells from peripheral blood	blood
12	chr17:15494200-15496800	Enhancers	Fetal Thymus	thymus
13	chr17:15494200-15497800	Enhancers	Primary neutrophils fromperipheralblood	blood
14	chr17:15494800-15496600	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
15	chr17:15495000-15495800	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
16	chr17:15495000-15496200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
17	chr17:15495200-15495600	Enhancers	Fetal Kidney	kidney
18	chr17:15495200-15495600	Enhancers	HUVEC	blood vessel
19	chr17:15495200-15495800	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr17:15495200-15496200	Enhancers	Cortex derived primary cultured neurospheres	brain
21	chr17:15495200-15511200	Weak transcription	Skeletal Muscle Female	skeletal muscle
22	chr17:15495400-15495600	Enhancers	Primary T cells from cord blood	blood
23	chr17:15495400-15495600	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
24	chr17:15495400-15498400	Weak transcription	Psoas Muscle	Psoas
25	chr17:15495600-15496600	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
26	chr17:15495800-15496200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
27	chr17:15496200-15496400	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
28	chr17:15496400-15496800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
29	chr17:15496600-15496800	Enhancers	Primary monocytes fromperipheralblood	blood
30	chr17:15496600-15496800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
31	chr17:15496600-15496800	Enhancers	Monocytes-CD14+_RO01746	blood
32	chr17:15496600-15497000	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
33	chr17:15499600-15500800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
34	chr17:15501000-15502000	Strong transcription	A549	lung
35	chr17:15502000-15522200	Weak transcription	A549	lung
36	chr17:15508800-15509200	Enhancers	Fetal Intestine Small	intestine
37	chr17:15508800-15509200	Enhancers	HepG2	liver
38	chr17:15509200-15511000	Weak transcription	HepG2	liver
39	chr17:15509200-15520200	Weak transcription	Fetal Intestine Small	intestine
40	chr17:15510200-15511000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
41	chr17:15511000-15511200	Enhancers	HepG2	liver
42	chr17:15511000-15511800	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
43	chr17:15511800-15512400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
44	chr17:15512800-15513000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr17:15513000-15522800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
46	chr17:15513600-15513800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
47	chr17:15515400-15536000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
48	chr17:15519600-15538400	Weak transcription	Skeletal Muscle Male	skeletal muscle
49	chr17:15520200-15520800	Enhancers	HepG2	liver
50	chr17:15520200-15522200	Enhancers	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links